86
Participants
Start Date
April 30, 2007
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Ixmyelocel-T
IM injection
Placebo
IM Injection
University of Pittsburgh Medical Center, Pittsburgh
University of North Carolina Hospitals, Chapel Hill
Malcolm Randall Veterans Administration Medical Center, part of the North Florida/South Georgia Veterans Health System, Gainesville
University of Miami/Miller School of Medicine, Miami
Cardiology, P.C., Birmingham
Jobst Vascular Center, Toledo
The Care Group, LLC, Indianapolis
VA Ann Arbor Healthcare System, Ann Arbor
St. Joseph Mercy Hospital, Ann Arbor
Michigan Vascular Research Center, Flint
Minneapolis Heart Institute Foundation, Minneapolis
Loyola University Stritch School of Medicine, Maywood
Southern Illinois University School of Medicine, Springfield
Oklahoma University, Oklahoma City
Scott and White Hospital, Temple
Peripheral Vascular Associates, San Antonio
Arizona Heart Institute, Phoenix
University of California, San Francisco, San Francisco
Dartmouth-Hitchcock Memorial Center, Lebanon
Vanderbilt University Medical Center, Nashville
Vericel Corporation
INDUSTRY